{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:29:23Z","timestamp":1793856563513,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.10.017","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T05:57:40Z","timestamp":1791698260000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overcoming Primary Graft Failure in Pediatric Allogeneic HSCT: Insights From Ten Centers of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)"],"prefix":"10.1016","author":[{"given":"Mariona","family":"Morell Daniel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Panesso Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5366-8384","authenticated-orcid":false,"given":"Maria Isabel","family":"Ben\u00edtez Carabante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Vinagre Enr\u00edquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Plaza Forniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"L\u00f3pez Torija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Urtasun Erburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3392-3285","authenticated-orcid":false,"given":"David","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1806-5761","authenticated-orcid":false,"given":"Graciela","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"P\u00e9rez Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Verd\u00fa Amor\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"P\u00e9rez Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Luz","family":"Ur\u00eda Oficialdegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Alonso Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Diaz-de-Heredia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jtct.2026.10.017_bib0001","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41409-025-02701-3","article-title":"Indications for haematopoietic cell transplantation and CAR-T for haematological diseases, solid tumours and immune disorders: 2025 EBMT Practice recommendations","volume":"60","author":"Greco","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.10.017_bib0002","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41409-017-0062-8","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the detection and treatment of donor-specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation","volume":"53","author":"Ciurea","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.10.017_bib0003","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.bbmt.2020.03.009","article-title":"Risk factors, clinical outcomes, and cost-of-care related to graft failure in pediatric allogeneic hematopoietic cell transplant recipients","volume":"26","author":"Wobma","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"10.1016\/j.jtct.2026.10.017_bib0004","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e151","article-title":"Incidence, management, and prognosis of graft failure and autologous reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"36","author":"Park","year":"2021","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.jtct.2026.10.017_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.10.017_bib0006","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.seminhematol.2018.08.004","article-title":"Poor graft function after allogeneic hematopoietic stem cell transplantation\u2014an old complication with new insights\u2606","volume":"56","author":"Kong","year":"2019","journal-title":"Semin Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.017_bib0007","doi-asserted-by":"crossref","first-page":"687.e1","DOI":"10.1016\/j.jtct.2021.04.030","article-title":"Donor-specific antibodies and primary graft failure in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"27","author":"Xie","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2026.10.017_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.13043","article-title":"T cell replete\u2013haploidentical second hematopoietic stem cell transplantation for primary graft failure in pediatric patients with hematologic malignancies","volume":"21","author":"Mochizuki","year":"2017","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.017_bib0009","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1517\/14656566.2014.852537","article-title":"Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Locatelli","year":"2014","journal-title":"Expert Opin Pharmacother"},{"issue":"12","key":"10.1016\/j.jtct.2026.10.017_bib0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00043426-200312000-00010","article-title":"Etiology and outcome of graft failure in pediatric hematopoietic stem cell transplant recipients","volume":"25","author":"Woodard","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.017_bib0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-0012.2010.01298.x","article-title":"Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review","volume":"25","author":"Chang","year":"2011","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.017_bib0012","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1182\/blood.V76.1.245.245","article-title":"Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation","volume":"76","author":"Nemunaitis","year":"1990","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.10.017_bib0013","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41409-020-01183-9","article-title":"Second haploidentical stem cell transplantation for primary graft failure","volume":"56","author":"Giammarco","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.jtct.2026.10.017_bib0014","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1038\/s41409-021-01310-0","article-title":"Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation","volume":"56","author":"Harada","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.10.017_bib0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/s41409-024-02251-0","article-title":"Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on Behalf of the EBMT, ASTCT, CIBMTR, and APBMT","volume":"59","author":"Sureda","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.017_bib0016","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","article-title":"Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell Transplantation: a report on behalf of the American Society for Transplantation and Cellular Th","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.017_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1704525","article-title":"Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme","volume":"34","author":"Khan","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2026.10.017_bib0017","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.bbmt.2009.07.004","article-title":"Defining the intensity of conditioning regimens: working definitions","volume":"15","author":"Bacigalupo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.10.017_bib0018","doi-asserted-by":"crossref","unstructured":"Angelucci E, Raiola AM Iron overload. In: Sureda A, Corbacioglu S, Greco R, Kr\u00f6ger N, Carreras E, editors. Cham (CH); 2024. p. 419\u201323.","DOI":"10.1007\/978-3-031-44080-9_46"},{"key":"10.1016\/j.jtct.2026.10.017_bib0019","doi-asserted-by":"crossref","unstructured":"The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. 7th ed. Cham (CH): Springer; 2019. https:\/\/doi.org\/10.1007\/978-3-030-02278-5. Carreras E, Dufour C, Mohty M, Kr\u00f6ger N, editors.","DOI":"10.1007\/978-3-030-02278-5"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.017_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.10.017_bib0021","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and Staging working group Report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.017_bib0023","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/16078454.2022.2042064","article-title":"Primary graft failure following allogeneic hematopoietic stem cell transplantation: risk factors, treatment and outcomes","volume":"27","author":"Chen","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.jtct.2026.10.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2019-124208","article-title":"Risk factors for primary and secondary graft failure in allogenic hematopoietic cell transplantation: a single center study","volume":"134","author":"Al-Shaibani","year":"2019","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2026.10.017_bib0025","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3109\/10428194.2014.930849","article-title":"Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients","volume":"56","author":"Ferr\u00e0","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.017_bib0026","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ajh.24111","article-title":"Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure","volume":"90","author":"Lund","year":"2015","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.017_bib0027","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/leu.2015.75","article-title":"Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies","volume":"29","author":"Olsson","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.jtct.2026.10.017_bib0028","first-page":"163","article-title":"Graft failure after allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Ozdemir","year":"2018","journal-title":"Transfus Apher Sci Off J World Apher Assoc Off J Eur Soc Haemapheresis"},{"key":"10.1016\/j.jtct.2026.10.017_bib0029","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025015971","article-title":"Outcome of second conditioned allogeneic stem cell transplant in children with non-SCID inborn errors of immunity","author":"Nademi","year":"2026","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2026.10.017_bib0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/14728214.2013.798642","article-title":"Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Servais","year":"2013","journal-title":"Expert Opin Emerg Drugs"},{"issue":"9","key":"10.1016\/j.jtct.2026.10.017_bib0031","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41409-023-02012-5","volume":"58","author":"Nagler","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.017_bib0032","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbmt.2008.05.005","article-title":"Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. results of a single institution analysis","volume":"14","author":"Rond\u00f3n","year":"2008","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.017_bib0033","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.bbmt.2010.02.013","article-title":"Second unrelated donor hematopoietic cell transplantation for primary graft failure","volume":"16","author":"Schriber","year":"2010","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2026.10.017_bib0034","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bmt.1703389","article-title":"Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation","volume":"29","author":"Wolff","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2026.10.017_bib0035","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s12015-025-10903-x","article-title":"Outcomes following second allogeneic stem cell transplant for graft failure or poor graft function: a single centre experience","volume":"21","author":"Kim","year":"2025","journal-title":"Stem Cell Rev Reports"},{"issue":"4","key":"10.1016\/j.jtct.2026.10.017_bib0036","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","article-title":"The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT","volume":"60","author":"Passweg","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.017_bib0037","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jtct.2025.06.007","article-title":"Conditioning regimens for second allogeneic hematopoietic stem cell transplantation for patients with primary graft failure","volume":"31","author":"Desai","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"9","key":"10.1016\/j.jtct.2026.10.017_bib0038","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bbmt.2012.02.014","article-title":"Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the Registry Data of the Japanese Society for Hematopoietic Cell Transplantation","volume":"18","author":"Fuji","year":"2012","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.017_bib0039","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","article-title":"High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation","volume":"88","author":"Ciurea","year":"2009","journal-title":"Transplantation"},{"issue":"1 Suppl 1","key":"10.1016\/j.jtct.2026.10.017_bib0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbmt.2007.10.025","article-title":"Graft failure after allogeneic hematopoietic cell transplantation","volume":"14","author":"Mattsson","year":"2008","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.017_bib0041","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13287-024-03726-z","article-title":"Graft failure after allogeneic hematopoietic stem cell transplantation in pediatric patients with acute leukemia: autologous reconstitution or second transplant?","volume":"15","author":"Rostami","year":"2024","journal-title":"Stem Cell Res Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726008055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726008055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:14:13Z","timestamp":1793855653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726008055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S2666636726008055"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.017","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overcoming Primary Graft Failure in Pediatric Allogeneic HSCT: Insights From Ten Centers of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}